Article
Lack of support for the inability to taste phenylthiocarbamide as an endophenotypic marker in patients with schizophrenia and their first-degree relatives.
Schizophrenia research - 1 Sept 2007
Compton Michael T, Chien Victoria H, Bollini Annie M, Walker Elaine F
Abstract excerpt
OBJECTIVE: This study sought to replicate recent findings that both patients and relatives are significantly more likely to be phenylthiocarbamide (PTC) nontasters than healthy controls, and that within the patient group, nontasters have more severe positive and/or negative symptoms than tasters. Associations between PTC-tasting status and olfactory identification scores also were examined. METHOD: PTC perception...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
